South San Francisco, Calif.
Went public 7/14/2000 at $12 per share
Filing Range: 5 mil. shares @ $11 to $13
Shares Outstanding: 25.8 mil. shares
Underwriters: Thomas Weisel Partners LLC/CIBC World Markets/Tucker Anthony Cleary Gull
Company Counsel: Wilson Sonsini Goodrich & Rosati
Manager Counsel: O’Melveny & Myers
Auditor: KPMG LLP
The Company:
Develops and manufactures new generation of painkillers.
Venture Backers:
TVM Techno Venture Management
Financing Rounds:
Number of Round Amt.
Round # Round Date Stage Investors ($ thousands)
1 10/15/1999 1 Expansion 1460.0
2 02/18/2000 2 Later Stage 15000.0
Financials:
(Data in $ millions)
Y/E
12/31/99
Total Revenues: $0.1
Net Income: -3.3